CD44 is an independent prognostic factor in early-stage cervical cancer

International Journal of Cancer

Volumn 74, Issue 2, 1997, Pages 185-188

  Speiser, Paul ^a   Wanner, Christian ^a   Tempfer, Clemens ^a   Mittelböck, Maria ^a   Hanzal, Engelbert ^a   Bancher Todesca, Dagmar ^a   Gitsch, Gerald ^a   Reinthaller, Alexander ^a   Kainz, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CANCER;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD44; ANTIGENS, NEOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0030985943     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970422)74:2<185::AID-IJC8>3.0.CO;2-V     Document Type: Article

References (29)

1. BURGHARDT, E., PICKEL, H., HAAS, J. and LAHOUSEN, M., Prognostic factors and operative treatment of stages IB to IIB cervical cancer. Amer. J. Obstet. Gynecol., 156, 988-996 (1987).
2. CANNISTRA, S.A., ABU-JAWDEH, G. and NILOFF, J., CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. J. clin. Oncol., 13, 1912-1921 (1995).
3. CAVALCANTI, G.B., SAVINO, W. and POMBO DE OLIVEIRA, M.S., CD44 expression in T-cell lymphoblastic leukemia. Braz. J. med. biol. Res., 27, 2259-2266 (1994).
4. COMBARET, V., GROSS, N., LASSET, C., FRAPPAZ, D., PERUISSEAU, G., PHILIP, T., BECK, D. and FAVROT, M.C., Clinical relevance of CD44 cell-surface expression and N-myc gene amplification in a multicentric analysis of 121 pediatric neuroblastomas. J. clin. Oncol., 14, 25-34 (1996).
5. DALL, P., HEIDER, K.H., HEKELE, A., VON MINCKWITZ, G., KAUFMANN, M., PONTA, H. and HERRLICH, P., Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal epithelium. Cancer Res., 54, 3337-3341 (1994).
6. DALL, P., HEIDER, K.H., SINN, H.P., SKROCH-ANGEL, P. and ADOLF, G., Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int. J. Cancer, 60, 471-477 (1995).
7. DALL, P., HEKELE, A., IKENBERG, H., GOPPINGER, A., BAUKNECHT, T., PFLEIDERER, A., MOLL, J., HOFMANN, M., PONTA, H. and HERRLICH, P., Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. Int. J. Cancer, 69, 79-85 (1996).
8. FIGGE, J., DEL ROSARIO, A.D. and GERASIMOV, G., Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp. mol. Pathol., 61, 203-211 (1994).
9. FOX, S.B., FAWCETT, J., JACKSON, D.G., COLLINS, I. and GATTER, K.C., Normal human tissues, in addition to some tumours, express multiple different CD44 isoforms. Cancer Res., 54, 4539-4546 (1994).
10. HERMANEK, P. and SOBIN, L., UICC TNM classification of malignant tumours. (4th ed., 2nd rev.) Springer, Berlin (1992).
11. HERRLICH, P., ZOELLER, M. and PALS, S., CD44 splice variants: metastases meet lymphocytes. Immunol. Today, 14, 395-399 (1993).
12. HUET, S., GROUX, H., CAILLOU, B., VALENTIN, H. and PRIEUR, A.M., CD44 contributes to T cell activation. J. Immunol., 143, 798-801 (1989).
13. JALKANEN, S., JOENSUU, H. and SODERSTRÖM, K.O., Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. clin. Invest., 87, 1835-1840 (1991).
14. JOENSUU, H., RISTAMAKI, R. and KLEMI, P.J., Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma. Brit. J. Cancer, 68, 428-432 (1993).
15. KAINZ, C., KOHLBERGER, P. and SLIUTZ, G., Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol. Oncol., 57, 383-387 (1995a).
16. KAINZ, C., KOHLBERGER, P., TEMPFER, C., SLIUTZ, G. and GITSCH, G., Prognostic value of CD44 splice variants in human cervical cancer stage III. Europ. J. Cancer, 31, 1706-1709 (1995b).
17. KAINZ, C., TEMPFER, C., WINKLER, S., SLIUTZ, G. and KOELBL, H., H., Serum CD44 splice variants in cervical cancer patients. Cancer Lett. 90, 231-234 (1995c).
18. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete observations. J. Amer. statist. Ass., 53, 457-481 (1958).
19. KAUFMANN, M., HEIDER, K.H. and SINN, H.P., CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet. 345, 615-619 (1995).
20. LI, H., LIU, J. and HOFMANN, M., Differential CD44 expression patterns in primary brain tumours and brain metastases. Brit. J. Cancer, 72, 160-163 (1995).
21. MATSUMURA, Y. and TARIN, D., Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340, 1053-1058 (1992).
22. MULDER, J.W., KRUYT, P.M., SEWNATH, M., OOSTING, J. and SELDENRIJK, C.A., Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet. 344, 1470-1472 (1994).
23. RISTAMAKI, R., JOENSUU, H., SONDERSTRÖM, K.O. and JALKANEN, S., CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J. Pathol., 176, 259-267 (1995).
24. SALMI, M., GRON-VIRTA, K., SOINTU, P., GREMAN, R., KALIMO, H. and JALKANEN, S., Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumours of squamocellular origin. J. Cell Biol., 122, 431-142 (1993).
25. SCREATON, G.R., BELL, M.V., JACKSON, D.G., CORNELIS, F.B. and GERTH, U., Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. nat. Acad. Sci. (Wash.), 89, 12160-12164 (1992).
26. SLIUTZ, G., TEMPFER, C., WINKLER, S., KOHLBERGER, P., REINTHALLER, A. and KAINZ, C. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer. Brit. J. Cancer. 72, 1494-1497 (1995).
27. SMITH, C.W., PATTON, J.G. and NADAL-GINARD, B., Alternative splicing in the control of gene expression. Ann. Rev. Genet., 23, 527-577 (1989).
28. STAMENKOVIC, I., ARUFFO, A., AMIOT, M. and SEED, B., The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J., 10, 343-348 (1991).
29. WIELENGA, V., HEIDER, K., OFFERHAUS, J., ADOLF, G. and VAN DEN BERG, F., Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res., 53, 4754-4756 (1993).